Short answer
NEOGENOMICS INC (NEO) filed an 8-K current report with the SEC on July 20, 2026 reporting Item 8.01 (Other Events), Item 7.01 (Regulation FD Disclosure). June 20, 2026 press release announces information related to the settlement agreement.
NEOGENOMICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- June 20, 2026 press release announces information related to the settlement agreement
- Settlement details appear under Item 8.01 and may affect NeoGenomics’ legal and financial outlook
Item 8.01 · Other Events
- $9.813M civil settlement with DOJ resolving investigation into consulting services for healthcare providers
- Settlement follows voluntary 2021 OIG-HHS notification concerning federal healthcare-law compliance
- $11.2M reserve previously accrued as of March 31, 2026, exceeding the settlement payment
- Agreement includes neither company admission of liability nor government concession on claim merits
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NEOGENOMICS INC 8-K filings
Get the next NEO 8-K as it lands
Follow NEO for push alerts, or ask the research agent what this filing means.